gemfibrozil has been researched along with Alzheimer Disease in 2 studies
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gemfibrozil is a drug that has been used for over 40 years to lower triglycerides in blood." | 1.91 | Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells. ( Bachmann, CM; Erhardt, T; Grimm, HS; Grimm, MOW; Hartmann, T; Janitschke, D; Lauer, AA, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, J | 3 |
| Mao, C | 3 |
| Hou, Y | 3 |
| Luo, Y | 3 |
| Binder, JL | 3 |
| Zhou, Y | 3 |
| Bekris, LM | 3 |
| Shin, J | 3 |
| Hu, M | 3 |
| Wang, F | 3 |
| Eng, C | 3 |
| Oprea, TI | 3 |
| Flanagan, ME | 3 |
| Pieper, AA | 3 |
| Cummings, J | 3 |
| Leverenz, JB | 3 |
| Cheng, F | 3 |
| Bachmann, CM | 1 |
| Janitschke, D | 1 |
| Lauer, AA | 1 |
| Erhardt, T | 1 |
| Hartmann, T | 1 |
| Grimm, MOW | 1 |
| Grimm, HS | 1 |
2 other studies available for gemfibrozil and Alzheimer Disease
| Article | Year |
|---|---|
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease.
Topics: Alzheimer Disease; Deep Learning; Drug Repositioning; Gemfibrozil; Genome-Wide Association Study; Hu | 2022 |
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease.
Topics: Alzheimer Disease; Deep Learning; Drug Repositioning; Gemfibrozil; Genome-Wide Association Study; Hu | 2022 |
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease.
Topics: Alzheimer Disease; Deep Learning; Drug Repositioning; Gemfibrozil; Genome-Wide Association Study; Hu | 2022 |
Interpretable deep learning translation of GWAS and multi-omics findings to identify pathobiology and drug repurposing in Alzheimer's disease.
Topics: Alzheimer Disease; Deep Learning; Drug Repositioning; Gemfibrozil; Genome-Wide Association Study; Hu | 2022 |
Gemfibrozil-Induced Intracellular Triglyceride Increase in SH-SY5Y, HEK and Calu-3 Cells.
Topics: Alzheimer Disease; Fatty Acids; Gemfibrozil; Humans; Hypolipidemic Agents; Neuroblastoma; Triglyceri | 2023 |